ℹ️
🇬🇧
Search
Search for people relevant for "prognostické markery"
prognostické markery
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Petr Dulíček Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
2 classes
419 publications
Classes
class
Physical Examination in Internal Medicine
FG10029 |
Faculty of Medicine in Hradec Králové
class
Clinical Examination in Internal Medicine
FGP031 |
Faculty of Medicine in Hradec Králové
Publications
publication
Prevention, diagnosis and treatment of cancer-associated thromboembolism
2023 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
publication
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
2023 |
Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
publication
Antithrombin Deficiency: Frequency in Patients with Thrombosis and Thrombophilic Families
2023 |
Faculty of Medicine in Hradec Králové
publication
Recommendations for thrombotic risk stratification and targeted thromboprophylaxis in women during assisted reproduction
2023 |
Publication without faculty affiliation
publication
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
2023 |
Publication without faculty affiliation
publication
Whole Blood Samples for Faster Real-Time PCR Analysis of Thrombophilic Mutations in SARS-CoV-2 Virus Positive Patients
2022 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Direct anticoagulants and general practitioner
2022 |
Faculty of Medicine in Hradec Králové
publication
Defects of Hemostasis in Clinical Practice
2022 |
Faculty of Medicine in Hradec Králové
publication
No Inhibitory Effect of Heparinized Blood on Real-Time PCR Analysis of Thrombophilic Mutations
2022 |
Faculty of Medicine in Hradec Králové
publication
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
2022 |
Publication without faculty affiliation
Load more publications (409)
Loading network view...